These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28240661)
21. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer? Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451 [TBL] [Abstract][Full Text] [Related]
27. Bone Flare to Androgen Deprivation Therapy in Metastatic, Hormone-Sensitive Prostate Cancer on 68Ga-Prostate-Specific Membrane Antigen PET/CT. Zacho HD; Petersen LJ Clin Nucl Med; 2018 Nov; 43(11):e404-e406. PubMed ID: 30222680 [TBL] [Abstract][Full Text] [Related]
28. Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer. Tulsyan S; Das CJ; Tripathi M; Seth A; Kumar R; Bal C Nucl Med Commun; 2017 Dec; 38(12):1094-1102. PubMed ID: 28957842 [TBL] [Abstract][Full Text] [Related]
29. 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls. Keidar Z; Gill R; Goshen E; Israel O; Davidson T; Morgulis M; Pirmisashvili N; Ben-Haim S Cancer Imaging; 2018 Nov; 18(1):39. PubMed ID: 30382889 [TBL] [Abstract][Full Text] [Related]
30. Subacute Cortical Infarct Showing Uptake on 68Ga-PSMA PET/CT. Chan M; Hsiao E Clin Nucl Med; 2017 Feb; 42(2):110-111. PubMed ID: 27997426 [TBL] [Abstract][Full Text] [Related]
31. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis. Lin CY; Lee MT; Lin CL; Kao CH Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999 [TBL] [Abstract][Full Text] [Related]
33. PET/CT With Giovacchini G; Giovannini E; Riondato M; Ciarmiello A Curr Radiopharm; 2018; 11(1):4-13. PubMed ID: 29090673 [TBL] [Abstract][Full Text] [Related]
34. Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma. Bhardwaj H; Stephens M; Bhatt M; Thomas PA Clin Nucl Med; 2016 Dec; 41(12):968-969. PubMed ID: 27749413 [TBL] [Abstract][Full Text] [Related]
35. Nonneoplastic Neuroma After Radical Prostatectomy Is Not a Mimicker of Lymph Node Metastases on 68Ga-PSMA Ligand PET/CT. Derlin T; Schumacher U; Bengel FM Clin Nucl Med; 2016 Oct; 41(10):785-6. PubMed ID: 27556791 [TBL] [Abstract][Full Text] [Related]
36. Detection Efficacy of Hybrid Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological predictors of positive Aydin AM; Haberal B; Artykov M; Bilen CY; Yazici S Ann Nucl Med; 2019 May; 33(5):326-332. PubMed ID: 30778860 [TBL] [Abstract][Full Text] [Related]
38. PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine: Differentiation in Patients With Castrate-Resistant Prostate Cancer. Gofrit ON; Frank S; Meirovitz A; Nechushtan H; Orevi M Clin Nucl Med; 2017 Jan; 42(1):1-6. PubMed ID: 27775942 [TBL] [Abstract][Full Text] [Related]